TR201911328T4 - İlaç, organik çözücü, lipofilik merhem bazı ve tozun harmanlanmasıyla elde edilen yapıştırıcı preparasyon bileşimi. - Google Patents

İlaç, organik çözücü, lipofilik merhem bazı ve tozun harmanlanmasıyla elde edilen yapıştırıcı preparasyon bileşimi. Download PDF

Info

Publication number
TR201911328T4
TR201911328T4 TR2019/11328T TR201911328T TR201911328T4 TR 201911328 T4 TR201911328 T4 TR 201911328T4 TR 2019/11328 T TR2019/11328 T TR 2019/11328T TR 201911328 T TR201911328 T TR 201911328T TR 201911328 T4 TR201911328 T4 TR 201911328T4
Authority
TR
Turkey
Prior art keywords
drug
organic solvent
patch preparation
powder
composition obtained
Prior art date
Application number
TR2019/11328T
Other languages
English (en)
Turkish (tr)
Inventor
Hamamoto Hidetoshi
Yamanaka Katsuhiro
Tanimoto Takahiro
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49768781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201911328(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Publication of TR201911328T4 publication Critical patent/TR201911328T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2019/11328T 2012-06-20 2013-06-18 İlaç, organik çözücü, lipofilik merhem bazı ve tozun harmanlanmasıyla elde edilen yapıştırıcı preparasyon bileşimi. TR201911328T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012139215 2012-06-20

Publications (1)

Publication Number Publication Date
TR201911328T4 true TR201911328T4 (tr) 2019-08-21

Family

ID=49768781

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/11328T TR201911328T4 (tr) 2012-06-20 2013-06-18 İlaç, organik çözücü, lipofilik merhem bazı ve tozun harmanlanmasıyla elde edilen yapıştırıcı preparasyon bileşimi.

Country Status (16)

Country Link
US (2) US10543275B2 (cg-RX-API-DMAC10.html)
EP (1) EP2865376B2 (cg-RX-API-DMAC10.html)
JP (1) JP6309892B2 (cg-RX-API-DMAC10.html)
CN (3) CN108553452A (cg-RX-API-DMAC10.html)
AU (1) AU2013278403B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014031701A2 (cg-RX-API-DMAC10.html)
CA (1) CA2875454C (cg-RX-API-DMAC10.html)
DK (1) DK2865376T4 (cg-RX-API-DMAC10.html)
ES (1) ES2738303T5 (cg-RX-API-DMAC10.html)
HU (1) HUE045479T2 (cg-RX-API-DMAC10.html)
IN (1) IN2014DN10706A (cg-RX-API-DMAC10.html)
PL (1) PL2865376T5 (cg-RX-API-DMAC10.html)
PT (1) PT2865376T (cg-RX-API-DMAC10.html)
SI (1) SI2865376T1 (cg-RX-API-DMAC10.html)
TR (1) TR201911328T4 (cg-RX-API-DMAC10.html)
WO (1) WO2013191187A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980920B2 (en) * 2013-09-11 2018-05-29 Medrx Co., Ltd. Base composition for tape agent
CN103830206B (zh) * 2014-02-26 2016-08-31 上海现代药物制剂工程研究中心有限公司 阿戈美拉汀三维网状立体构型的透皮给药制剂及制备方法
US10045948B2 (en) 2014-02-27 2018-08-14 Medrx Co., Ltd. Pramipexole-containing transdermal patch for treatment of neurodegenerative disease
WO2016109483A1 (en) * 2014-12-30 2016-07-07 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems for agomelatine
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
CN107427509B (zh) * 2015-08-29 2021-06-15 美德阿利克斯株式会社 含有碱性药物和山梨酸的经皮吸收组成物
ES2957234T3 (es) 2016-03-24 2024-01-15 Medrx Co Ltd Preparación de parche con características de prevención del uso incorrecto de sustancias
CN109923186A (zh) * 2016-11-09 2019-06-21 株式会社可乐丽 粘合片、橡皮膏及它们的制造方法
CN113164423A (zh) * 2018-10-04 2021-07-23 美德阿利克斯株式会社 用非水溶剂稳定化的制剂
JPWO2022173006A1 (cg-RX-API-DMAC10.html) * 2021-02-12 2022-08-18
JP7179212B1 (ja) 2022-05-02 2022-11-28 久光製薬株式会社 リドカイン含有貼付剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3144895B2 (ja) 1992-06-30 2001-03-12 積水化学工業株式会社 医療用粘着テープもしくはシート
JPH06145050A (ja) 1992-11-11 1994-05-24 Sekisui Chem Co Ltd 貼付剤の製造方法
JPH07145047A (ja) 1993-11-25 1995-06-06 Sekisui Chem Co Ltd 局所麻酔用経皮吸収テープ
JPH0827003A (ja) 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
JPH09169636A (ja) 1995-06-12 1997-06-30 Sekisui Chem Co Ltd 貼付剤
JPH09136834A (ja) 1995-11-14 1997-05-27 Sekisui Chem Co Ltd 経皮吸収貼付剤
JP4648518B2 (ja) * 2000-06-01 2011-03-09 帝國製薬株式会社 4−ビフェニル酢酸含有貼付剤
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US6503532B1 (en) 2001-04-13 2003-01-07 Murty Pharmaceuticals, Inc. Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof
AU2003272878A1 (en) * 2002-09-13 2004-04-30 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
US8080261B2 (en) * 2004-09-30 2011-12-20 Teikoku Pharma Usa, Inc. 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
WO2008032719A1 (en) 2006-09-11 2008-03-20 Sekisui Chemical Co., Ltd. Adhesive preparation
JP4148988B2 (ja) * 2006-09-11 2008-09-10 積水化学工業株式会社 貼付剤
CN103239721B (zh) * 2007-11-22 2016-03-16 美德阿利克斯株式会社 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物
EP2258396B1 (en) 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP4822032B2 (ja) 2009-01-08 2011-11-24 タイヨーエレック株式会社 組合せ式遊技機
WO2010113225A1 (en) * 2009-03-30 2010-10-07 Yutoku Pharmaceutical Industries Co., Ltd. Riluzole-containing transdermal patch
DE102009022915A1 (de) * 2009-05-27 2010-12-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit gesteuertem Wirkstofffluss
JP2011074035A (ja) 2009-09-30 2011-04-14 Sekisui Medical Co Ltd 貼付剤

Also Published As

Publication number Publication date
PL2865376T3 (pl) 2019-12-31
AU2013278403A1 (en) 2015-01-22
DK2865376T4 (da) 2022-07-18
JPWO2013191187A1 (ja) 2016-05-26
WO2013191187A1 (ja) 2013-12-27
BR112014031701A2 (pt) 2017-06-27
EP2865376B2 (en) 2022-05-11
JP6309892B2 (ja) 2018-04-11
US20150174249A1 (en) 2015-06-25
ES2738303T5 (es) 2022-09-12
HUE045479T2 (hu) 2019-12-30
AU2013278403B2 (en) 2018-02-01
SI2865376T1 (sl) 2019-11-29
US10543275B2 (en) 2020-01-28
CN110693859A (zh) 2020-01-17
ES2738303T3 (es) 2020-01-21
CN108553452A (zh) 2018-09-21
PT2865376T (pt) 2019-08-26
EP2865376A4 (en) 2015-11-18
EP2865376B1 (en) 2019-06-05
US12016924B2 (en) 2024-06-25
EP2865376A1 (en) 2015-04-29
DK2865376T3 (da) 2019-08-12
CA2875454A1 (en) 2013-12-27
IN2014DN10706A (cg-RX-API-DMAC10.html) 2015-09-04
CA2875454C (en) 2021-02-16
PL2865376T5 (pl) 2023-01-09
CN104363900A (zh) 2015-02-18
US20190388544A1 (en) 2019-12-26

Similar Documents

Publication Publication Date Title
CL2018003681A1 (es) Derivados de ácido borónico y usos terapéuticos de los mismos
CY1120521T1 (el) Παρασκευασμα προμειγματος δεξμεδετομιδινης
GT201200334A (es) Morfolinopirimidinas y su uso en terapia
BR112015008487A2 (pt) compostos de benzeno substituído
CO6721010A2 (es) Antagonistas de mdm2 de espiro-oxindol
DK2811981T3 (da) Forbedrede adjuvansformuleringer, der omfatter tlr4-agonister, og fremgangsmåder til anvendelse heraf
GT201200321A (es) Derivados de heteroaril imidazolona como inhibidores de jak
HUE045479T2 (hu) Tapadó preparátum készítmény, amely elõállítható gyógyszerhatóanyag, szerves oldószer, lipofil kenõcsalap és por összekeverésével
CL2010001475A1 (es) Compuestos derivados de ester boronato, inhibidores de proteasoma; composiciones farmaceuticas que los contienen; procedimiento de preparacion de la composición farmaceutica; utiles en el tratamiento de enfermedades proliferativas celulares, en particular cancer.
BR112012024835A2 (pt) adesivo de distribuição transdérmica
TR201908697T4 (tr) Yüksek yüzey alanlı karbonlu maddeler içeren aktif madde bileşimlerin yapımı için usul.
BR112012017580A2 (pt) derivados de heteroarila contendo nitrogênio
BR112013001550A2 (pt) composições, dispositivos e métodos de adesivos trandérmicos
BR112013030644A2 (pt) fosfolipídios contendo ácido(s) nitrocarboxílico(s) da estrutura geral (i), e uso dos mesmos, dispositivo médico e composições biopassivadoras
PE20151979A1 (es) Compuestos quimicos
EA201390090A1 (ru) Дезинфицирующий и антисептический препарат, имеющий сниженное содержание йода
BR112012009310B8 (pt) composto derivados de 2-oxo-1-pirrolidinil imidazotiadiazol, uso dos mesmos e composição farmacêutica compreendendo os mesmos
CY1123805T1 (el) Διαδερμικο σκευασμα που περιεχει αναστολεις cox
BR112013017570A2 (pt) compostos de pirazola como antagonistas de crth2
MX2023003000A (es) Formulaciones de liberacion modificada de viloxacina.
EA201390980A1 (ru) Лекарственный пластырь для улучшенного трансдермального проникновения диклофенака диэтиламмония
HK1223852A1 (zh) 睪丸酮凝膠組合物及相關方法
CY1122538T1 (el) Συμπλεγματα χονδροϊτινης για διαδερμικη απορροφηση
CL2014002115A1 (es) Solución oxidante que contiene una mezcla de oxidante disuelto para la preparacion de formulaciones de explosivos; formulacion de explosivos.
BR112014018426A8 (pt) Composição e dispositivo para administração transdérmica, e, método para administrar uma progestina